Form 4 for ELV Elevance Health
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001156039-23-000104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-10-04 | 2023-10-02 | ELV | Kaye Mark | EVP, CFO Designate | A - Grant | $0.00 | +20.3K | 18.2K | New | $0 |
| D | 2023-10-04 | 2023-10-02 | ELV | Kaye Mark | EVP, CFO Designate | A - Grant | $0.00 | +8,076 | 8,076 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-02 | A | A | 2,102 | $0.00 | 20,276 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 700 shares on 10/2/2024 and 701 shares each on 10/2/2025 and 10/2/2026. |
| 2 | Common | Common Stock | 2023-10-02 | A | A | 18,174 | $0.00 | 18,174 | D | — | — | (F1) Represents restricted share units. Restrictions lapse as follows: 6,058 shares each on 10/2/2024, 10/2/2025 and 10/2/2026. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-10-02 | A | A | 8,076 | $0.00 | 8,076 | D | $440.19 · — to 2033-10-02 | 8,076 Common Stock | (F3) The option represents a right to purchase a total of 8,076 shares, and is exercisable in three annual installments of 2,692 shares each, beginning on 10/2/2024, which is the one-year anniversary of the option grant date. |